Design, synthesis and anti-fibrosis activity study of N 1- substituted phenylhydroquinolinone derivatives

Molecules

Volumn 17, Issue 2, 2012, Pages 1373-1387

  Wu, Ling ^a   Liu, Bin ^b   Li, Qianbin ^a   Chen, Jun ^a   Tao, Lijian ^b   Hu, Gaoyun ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Anti fibrosis; N 1 substituted phenylhydroquinolinones; Synthesis

Indexed keywords

QUINOLONE DERIVATIVE;

ARTICLE; DRUG DESIGN; FIBROSIS; HUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; SYNTHESIS;

DRUG DESIGN; FIBROSIS; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; QUINOLONES;

EID: 84863127185     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules17021373     Document Type: Article

References (20)

1. Povero, D.; Busletta, C.; Novo, E.; di Bonzo, L.V.; Cannito, S.; Paternostro, C.; Parola, M. Liver fibrosis: A dynamic and potentially reversible process. Histol. Histopathol. 2010, 25, 1075-1091.
2. Huang, X.; Gai, Y.; Yang, N.; Lu, B.; Samuel, C.S.; Thannickal, V.J.; Zhou, Y. Relaxin regulates myofibroblast contractility and protects against lung fibrosis. Am. J. Pathol. 2011, 179, 2751-2765.
3. Border, W.A.; Noble, N.A. Transforming growth factor beta in tissue fibrosis. N. Engl. J. Med. 1994, 331, 1286-1292. (Pubitemid 24333194)
4. Stramer, B.M.; Mori, R.; Martin, P. The inflammation-fibrosis link? A Jekyll and Hyde role for blood cells during wound repair. J. Invest. Dermatol. 2007, 127, 1009-1017. (Pubitemid 46625163)
5. Munger, J.S.; Huang, X.; Kawakatsu, H.; Griffiths, M.J.; Dalton, S.L.; Wu, J.; Pittet, J.F.; Kaminski, N.; Garat, C.; Matthay, M.A.; et al. The integrin alpha v beta 6 binds and activates latent TGF beta 1: A mechanism for regulating pulmonary inflammation and fibrosis. Cell 1999, 96, 319-328. (Pubitemid 29077586)
6. Kisseleva, T.; Brenner, D.A. Mechanisms of fibrogenesis. Exp. Biol. Med. (Maywood) 2008, 233, 109-122. (Pubitemid 351231543)
7. Friedman, S.L. Mechanisms of hepatic fibrogenesis. Gastroenterology 2008, 134, 1655-1669. (Pubitemid 351615417)
8. Mu, X.; Bellayr, I.; Walters, T.; Li, Y. Mediators leading to fibrosis - How to measure and control them in tissue engineering. Oper. Tech. Orthop. 2010, 20, 110-118.
9. Ruster, C.; Wolf, G. Angiotensin II as a morphogenic cytokine stimulating renal fibrogenesis. J. Am. Soc. Nephrol. 2011, 22, 1189-1199.
10. Moran, N. p38 kinase inhibitor approved for idiopathic pulmonary fibrosis. Nat. Biotechnol. 2011, 29, 301.
11. Wynn, T.A. Cellular and molecular mechanisms of fibrosis. J. Pathol. 2008, 214, 199-210. (Pubitemid 351160157)
12. Nakayama, S.; Mukae, H.; Sakamoto, N.; Kakugawa, T.; Yoshioka, S.; Soda, H.; Oku, H.; Urata, Y.; Kondo, T.; Kubota, H.; et al. Pirfenidone inhibits the expression of HSP47 in TGF-beta1-stimulated human lung fibroblasts. Life Sci. 2008, 82, 210-217.
13. Grattendick, K.J.; Nakashima, J.M.; Feng, L.; Giri, S.N.; Margolin, S.B. Effects of three anti-TNF-alpha drugs: etanercept, infliximab and pirfenidone on release of TNF-alpha in medium and TNF-alpha associated with the cell in vitro. Int. Immunopharmacol. 2008, 8, 679-687.
14. Levy, H.; Murphy, A.; Zou, F.; Gerard, C.; Klanderman, B.J.; Schuemann, B.; Lazarus, R.; García, K.C.; Celedón, J.C.; Drumm, M.; et al. Polymorphisms in the IL-1 gene family and lung disease severity in patients with cystic fibrosis. Proc. Am. Thorac. Soc. 2008, 5, 373-374.
15. Taniguchi, H.; Ebina, M.; Kondoh, Y.; Ogura, T.; Azuma, A.; Suga, M.; Taguchi, Y.; Takahashi, H.; Nakata, K.; Sato, A.; et al. Pirfenidone in idiopathic pulmonary fibrosis. Eur. Respir. J. 2010, 35, 821-829.
16. Yuan, Q.; Wang, R.; Peng, Y.; Fu, X.; Wang, W.; Wang, L.; Zhang, F.; Peng, Z.; Ning, W.; Hu, G.; et al. Fluorofenidone attenuates tubulointerstitial fibrosis by inhibiting TGF-beta(1)-induced fibroblast activation. Am. J. Nephrol. 2011, 34, 181-194.
17. Giri, S.N.; Wang, Q.; Xie, Y.; Lango, J.; Morin, D.; Margolin, S.B.; Buckpitt, A.R. Pharmacokinetics and metabolism of a novel antifibrotic drug pirfenidone, in mice following intravenous administration. Biopharm. Drug Dispos. 2002, 23, 203-211. (Pubitemid 34812311)
18. Yermolayev, S.A.; Gorobets, N.Y.; Lukinova, E.V.; Shishkin, O.V.; Shishkina, S.V.; Desenko, S.M. An efficient synthesis of N1-substituted 2,5-dioxo-1,2,5,6,7,8-hexahydro-3-quinoline carboxamide via enolate salts. Tetrahedron 2008, 64, 4649-4655.
19. Soni, R.; Collinson, J.M.; Clarkson, G.C.; Wills, M. An unexpected directing effect in the asymmetric transfer hydrogenation of alpha,alpha-disubstituted ketones. Org. Lett. 2011, 13, 4304-4307.
20. Rosen, W.E.; Green, M.J. The reduction of 2-indanone oxime to 2-aminoindane. Methods and mechanisms. J. Org. Chem. 1963, 28, 2797-2804.